MarketInOut Stock Screener Log In | Sign Up
 

PharmGen Science Inc

KRX • Healthcare • Drug Manufacturers - General • Quote as of 09/18/2026
PharmGen Science Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeKRX
Market Capitalization63,327 mln
Float13.46 mln

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-6.59
Highly reliable

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-97%
Severely loss-making

ROE

-72.25
Deeply negative

Business Description

Founded in 1957 and based in Hwaseong-si, South Korea, PharmGen Science Inc. is a long-established company that makes and sells a wide range of health and personal care products. Its lineup includes medicines available by prescription or over the counter, diagnostic kits, food supplements, cosmetics, and hair care items sold under the Neomcell brand.

Key Fundamentals

EPS-7,089
ROE-72.25
RPS9,471
ROIC1.54
ROA-54.14
Interest Cover9.33
EBITDA, mln-146,820
EV / EBITDA-0.35
EV / EBIT-0.34
Revenue, mln175,361
EV / Revenue0.30

Quote Details

Last 2,850.00
Change -35 (-1.21%)
Open 2,890.00
Volume 29,683
Turnover 84,596,552
Average Volume 16,224

Financial Ratios

Pre-Tax Profit Margin-97
Leverage Ratio1.32
Current Ratio3.33
Price / Book0.51
Price / Tangible Book0.54
Price / Cash Flow3.69
Price / Free Cash Flow5.13
Debt / Equity0.01
Price / Sales0.40

Financial Strength

Altman Z-Score-0.65
Piotroski F-Score 5 / 9
Beneish M-Score-6.59
Price to Intrinsic Value1.17
Shiller PE Ratio30.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.79% 7 / 100   
1 Month -10.94% 9 / 100   
2 Months -10.8% 44 / 100   
6 Months -23.9% 35 / 100   
1 Year -35.15% 19 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us